XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -35.55%410.47M | 35.07%154.83M | -26.21%129.6M | -49.50%141.95M | -124.30%-15.92M | -6.85%636.88M | -43.33%114.63M | -2.09%175.65M | 20.68%281.08M | -5.26%65.52M |
Net income from continuing operations | -38.81%251.6M | -37.81%54.29M | -31.50%65.45M | -35.88%68.16M | -47.79%63.7M | -37.51%411.15M | -40.87%87.3M | -42.51%95.55M | -39.55%106.29M | -27.48%122.01M |
Operating gains losses | 1.80%-71.66M | 123.77%8.98M | -257.63%-26.22M | 49.81%-13.11M | -60.54%-41.31M | -173.88%-72.97M | -139.65%-37.76M | 2.06%16.64M | -138.44%-26.12M | -184.92%-25.73M |
Depreciation and amortization | -9.75%89.32M | -34.15%22.15M | 0.65%22.45M | 3.97%22.22M | 3.90%22.49M | 26.90%98.97M | 61.98%33.64M | 13.35%22.31M | 12.89%21.38M | 16.32%21.65M |
Deferred tax | -8.26%-17.94M | -6.91%-8.15M | -3.68%-5.56M | -61.99%-10.83M | 112.83%6.6M | -253.27%-16.57M | -197.09%-7.63M | -54.54%-5.36M | -820.37%-6.69M | -43.53%3.1M |
Other non cash items | 16.29%-29.21M | 1.32%-6.33M | 11.73%-7.32M | 26.33%-7.17M | 19.76%-8.39M | 13.53%-34.9M | 39.81%-6.42M | 18.33%-8.3M | 3.46%-9.73M | -10.49%-10.46M |
Change In working capital | -34.02%119.62M | 122.64%65.76M | 78.99%63.18M | -62.94%66.66M | -19.81%-75.98M | 196.53%181.31M | -16.89%29.54M | 242.26%35.3M | 582.44%179.89M | 60.68%-63.41M |
-Change in receivables | -57.15%66.95M | 3.59%92.9M | -19.70%16.58M | -198.09%-35.48M | -172.06%-7.04M | 338.12%156.27M | -3.18%89.68M | 173.01%20.64M | 189.56%36.17M | 110.91%9.77M |
-Change in payables and accrued expense | 42.35%-37.88M | 73.69%-28.59M | -82.44%4.16M | -27.98%65.75M | -9.93%-79.2M | -26.99%-65.7M | -42.76%-108.63M | 610.77%23.67M | 93.48%91.3M | -295.93%-72.05M |
-Change in other working capital | -0.22%90.55M | -97.02%1.45M | 570.58%42.45M | -30.59%36.39M | 1,001.40%10.27M | 228.79%90.74M | 155.14%48.48M | -211.43%-9.02M | 218.90%52.42M | 97.87%-1.14M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -35.55%410.47M | 35.07%154.83M | -26.21%129.6M | -49.50%141.95M | -124.30%-15.92M | -6.85%636.88M | -43.33%114.63M | -2.09%175.65M | 20.68%281.08M | -5.26%65.52M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 22.39%-87.12M | -37.09%-29.01M | -55.25%-20.64M | -2.72%-15.43M | 64.90%-22.03M | 3.75%-112.25M | 52.36%-21.16M | 21.80%-13.3M | 46.51%-15.02M | -131.47%-62.77M |
Capital expenditure reported | -22.77%-56.32M | -22.01%-14.31M | -18.48%-17.84M | -27.46%-12.39M | -25.73%-11.78M | 24.94%-45.87M | 6.07%-11.73M | -12.68%-15.06M | 52.07%-9.72M | 37.49%-9.37M |
Net business purchase and sale | 74.49%-264K | --0 | --0 | 21.19%-264K | --0 | 94.55%-1.04M | --0 | --0 | ---335K | ---700K |
Net investment purchase and sale | 53.27%-30.54M | -55.82%-14.71M | -259.52%-2.81M | 44.16%-2.77M | 80.54%-10.25M | -78.92%-65.34M | 27.15%-9.44M | 148.30%1.76M | 36.34%-4.96M | -334.44%-52.7M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 22.39%-87.12M | -37.09%-29.01M | -55.25%-20.64M | -2.72%-15.43M | 64.90%-22.03M | 3.75%-112.25M | 52.36%-21.16M | 21.80%-13.3M | 46.51%-15.02M | -131.47%-62.77M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -7.80%-496.44M | -26.52%-134.62M | 28.60%-103.38M | -24.54%-115.05M | -22.60%-143.39M | 9.55%-460.54M | 2.15%-106.41M | -0.82%-144.79M | 37.27%-92.38M | -6.76%-116.96M |
Net common stock issuance | -8.41%-276.03M | -44.40%-80.48M | 47.62%-49.36M | -45.59%-60.3M | -35.80%-85.89M | 20.40%-254.63M | 10.17%-55.74M | 3.10%-94.22M | 57.97%-41.42M | -1.90%-63.24M |
Cash dividends paid | -7.04%-220.41M | -6.85%-54.14M | -6.84%-54.02M | -7.42%-54.75M | -7.05%-57.5M | -8.78%-205.91M | -8.52%-50.67M | -9.05%-50.56M | -4.58%-50.96M | -13.09%-53.72M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -7.80%-496.44M | -26.52%-134.62M | 28.60%-103.38M | -24.54%-115.05M | -22.60%-143.39M | 9.55%-460.54M | 2.15%-106.41M | -0.82%-144.79M | 37.27%-92.38M | -6.76%-116.96M |
Net cash flow | ||||||||||
Beginning cash position | 11.10%731.74M | -21.80%570.47M | -24.27%547.37M | -1.24%540.94M | 11.10%731.74M | 6.40%658.63M | 22.94%729.47M | 22.31%722.76M | -0.47%547.73M | 6.40%658.63M |
Current changes in cash | -370.05%-173.09M | 31.93%-8.81M | -68.23%5.58M | -93.39%11.48M | -58.78%-181.34M | 10.62%64.1M | -126.34%-12.94M | -6.53%17.56M | 201.74%173.68M | -69.16%-114.21M |
Effect of exchange rate changes | -333.60%-21.07M | -258.37%-24.08M | 261.40%17.52M | -472.40%-5.05M | -385.60%-9.46M | 149.23%9.02M | -5.95%15.2M | 33.62%-10.85M | 107.98%1.36M | 386.75%3.31M |
End cash Position | -26.53%537.58M | -26.53%537.58M | -21.80%570.47M | -24.27%547.37M | -1.24%540.94M | 11.10%731.74M | 11.10%731.74M | 22.94%729.47M | 22.31%722.76M | -0.47%547.73M |
Free cash flow | -40.08%354.15M | 36.56%140.53M | -30.40%111.76M | -52.25%129.56M | -149.33%-27.7M | -5.08%591.01M | -45.78%102.91M | -3.28%160.59M | 27.62%271.36M | 3.65%56.15M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |